Skip to main content
SpringerLink
Log in

Treatment of Peritoneal Metastases from Breast Cancer by Maximal Cytoreduction and HIPEC

  • Chapter
  • First Online:
Unusual Cases in Peritoneal Surface Malignancies

  • 421 Accesses

Abstract

Please confirm if identified heading levels are okay.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  PubMed  Google Scholar 

  2. Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8.

    Google Scholar 

  3. American Cancer Society. Cancer facts and figures: American Cancer Society, Inc. 2003. Available at http://www.cancer.org/downloads/stt/caff2003pwsecured.pdf.

  4. Bertozzi S, Londero AP, Cedolini C, Uzzau A, Seriau L, Bernardi S, et al. Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. Springerplus. 2015;4:688.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449–56.

    Article  PubMed  Google Scholar 

  6. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237–42.

    Article  PubMed  Google Scholar 

  7. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28(1):63–8.

    Article  PubMed  Google Scholar 

  8. Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol. 2013;39(12):1435–43.

    Article  CAS  PubMed  Google Scholar 

  9. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–81.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Elias D, David A, Sourrouille I, Honoré C, Goéré D, Dumont F, et al. Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). Surgery. 2014;155(1):5–12.

    Article  PubMed  Google Scholar 

  11. Baratti D, Pennacchioli E, Kusamura S, Fiore M, Balestra MR, Colombo C, et al. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol. 2010;17(12):3220–8.

    Article  PubMed  Google Scholar 

  12. Kallianpur AA, Shukla NK, Deo SV, Yadav P, Mudaly D, Yadav R, et al. Updates on the multimodality management of desmoplastic small round cell tumor. J Surg Oncol. 2012;105(6):617–21.

    Article  PubMed  Google Scholar 

  13. Cardi M, Sammartino P, Mingarelli V, Sibio S, Accarpio F, Biacchi D, et al. Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis. World J Surg Oncol. 2015;13:305.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  CAS  PubMed  Google Scholar 

  16. Cardi M, Sammartino P, Framarino ML, Biacchi D, Cortesi E, Sibio S, et al. Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 cases. Breast. 2013;22(5):845–9.

    Article  PubMed  Google Scholar 

  17. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.

    Article  CAS  PubMed  Google Scholar 

  18. Sugar Baker PH. In: Sugarbaker PH, editor. Peritoneal carcinomatosis. Principles of management. Boston: Kluwer Academic; 1996.

    Google Scholar 

  19. Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113(2):315–25.

    Article  PubMed  Google Scholar 

  20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I. Clinical implications of metastases to the ovary. Gynecol Oncol. 1995;59(1):124–8.

    Article  CAS  PubMed  Google Scholar 

  22. Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors influencing survival. Obstet Gynecol. 1975;45(4):391–6.

    CAS  PubMed  Google Scholar 

  23. Sheen-Chen SM, Liu YW, Sun CK, Lin SE, Eng HL, Huang WT, et al. Abdominal carcinomatosis attributed to metastatic breast carcinoma. Dig Dis Sci. 2008;53(11):3043–5.

    Article  PubMed  Google Scholar 

  24. Curtin JP, Barakat RR, Hoskins WJ. Ovarian disease in women with breast cancer. Obstet Gynecol. 1994;84(3):449–52.

    CAS  PubMed  Google Scholar 

  25. Abu-Rustum NR, Aghajanian CA, Venkatraman ES, Feroz F, Barakat RR. Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol. 1997;66(1):41–4.

    Article  CAS  PubMed  Google Scholar 

  26. Nazareno J, Taves D, Preiksaitis HG. Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature. World J Gastroenterol. 2006;12(38):6219–24.

    Article  PubMed  PubMed Central  Google Scholar 

  27. McLemore EC, Pockaj BA, Reynolds C, Gray RJ, Hernandez JL, Grant CS, et al. Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis. Ann Surg Oncol. 2005;12(11):886–94.

    Article  PubMed  Google Scholar 

  28. Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 2005;29(11):1482–9.

    Article  PubMed  Google Scholar 

  29. Silberstein GB, Van Horn K, Strickland P, Roberts Jr CT, Daniel CW. Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A. 1997;94(15):8132–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Chhieng DC, Rodriguez-Burford C, Talley LI, Sviglin H, Stockard CR, Kleinberg MJ, et al. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma. Hum Pathol. 2003;34(10):1016–21.

    Article  CAS  PubMed  Google Scholar 

  31. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20(3):281–7.

    Article  CAS  PubMed  Google Scholar 

  32. Ayhan A, Tuncer ZS, Bükülmez O. Malignant tumors metastatic to the ovaries. J Surg Oncol. 1995;60(4):268–76.

    Article  CAS  PubMed  Google Scholar 

  33. Eitan R, Gemignani ML, Venkatraman ES, Barakat RR, Abu-Rustum NR. Breast cancer metastatic to abdomen and pelvis: role of surgical resection. Gynecol Oncol. 2003;90(2):397–401.

    Article  PubMed  Google Scholar 

  34. Bigorie V, Morice P, Duvillard P, Antoine M, Cortez A, Flejou JF, et al. Ovarian metastases from breast cancer: report of 29 cases. Cancer. 2010;116(4):799–804.

    Article  PubMed  Google Scholar 

  35. Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012;256(2):334–41.

    Article  PubMed  Google Scholar 

  36. Chan DL, Morris DL, Rao A, Chua TC. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res. 2012;4:413–22.

    PubMed  PubMed Central  Google Scholar 

  37. Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat Rev. 2004;30(1):53–81.

    Article  CAS  PubMed  Google Scholar 

  38. Shamseddine AI, Farhat FS. Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy. 2011;57(6):468–87.

    Article  CAS  PubMed  Google Scholar 

  39. Elias D. Is intraperitoneal chemotherapy after cytoreductive surgery efficient? Knowing whether it is or not appears secondary! Ann Surg Oncol. 2012;19(1):5–6.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

No conflict of interest to disclose.

Author information

Authors and Affiliations

  1. University of Rome “Sapienza”, Department Pietro Valdoni, Policlinico Umberto I, Viale del Policlinico 155, 00161, Rome, Italy

    Paolo Sammartino MD, PhD, Maurizio Cardi MD, PhD, Tommaso Cornali MD, Bianca Maria Sollazzo MD, Rosa Marcellinaro MD, Alessio Impagnatiello MD & Di Giorgio Angelo MD

Authors
  1. Paolo Sammartino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio Cardi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tommaso Cornali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bianca Maria Sollazzo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosa Marcellinaro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessio Impagnatiello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Di Giorgio Angelo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Sammartino MD, PhD .

Editor information

Editors and Affiliations

  1. Peritoneal Dissemination Treatment, Istanbul, Turkey

    Emel Canbay

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Sammartino, P. et al. (2017). Treatment of Peritoneal Metastases from Breast Cancer by Maximal Cytoreduction and HIPEC. In: Canbay, E. (eds) Unusual Cases in Peritoneal Surface Malignancies . Springer, Cham. https://doi.org/10.1007/978-3-319-51523-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51523-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51522-9

  • Online ISBN: 978-3-319-51523-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation